Medical News

RSS

KHCC, Global Bridges to start tobacco treatment training for EMRO health care providers

Global Bridges, a healthcare alliance for tobacco dependence treatment based at Mayo Clinic, and its regional partner, King Hussein Cancer Center in Amman, Jordan, announced today that they will start training health care providers in the Eastern Mediterranean Region on how to successfully treat tobacco users.

27 Apr 2011

LSP announces initial public offering of Life Sciences Fund on NYSE Euronext

LSP Advisory B.V., a group company of LSP, one of Europe's largest and most reputable specialized healthcare and biotechnology investment firms, today announced the initial public offering of the LSP Life Sciences Fund N.V. on NYSE Euronext Amsterdam.

27 Apr 2011

Karo Bio reports net loss of MSEK 47.7 for January - March 2011

Karo Bio: The January - March 2011 period in brief. Net sales amounted to MSEK 0.0.

27 Apr 2011

ISCO completes first series of hepatocytes preclinical testing

International Stem Cell Corporation announces successful completion of the first series of preclinical testing of hepatocytes derived in the lab from human parthenogenetic stem cells.

27 Apr 2011

Biologists determine molecular structure of GluN2D receptor subunit

Structural biologists at Cold Spring Harbor Laboratory in collaboration with colleagues at Emory University have determined the molecular structure of a key portion, or subunit, of a receptor type commonly expressed in brain cells.

27 Apr 2011

Major breakthrough in understanding of amyotrophic lateral sclerosis

Brandeis researchers have made a significant advance in the effort to understand amyotrophic lateral sclerosis by successfully reversing the toxicity of the mutated protein in the familial type of the disease.

27 Apr 2011

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.

27 Apr 2011

Sagent Pharma closes initial public offering of 5,750,000 shares of common stock

Sagent Pharmaceuticals, Inc. today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.

27 Apr 2011

Dems eye Ryan Medicare plan as political opportunity

With Obama administration officials part of the campaign against the Ryan plan, other opponents also are stepping forward and launching a new wave of television ads in Wisconsin Republican Rep. Paul Ryan's very own congressional district. Meanwhile, The Washington Post analyzes some of the poll numbers behind where voters may stand on Medicare cuts.

27 Apr 2011

Researchers investigate new device that can recognize early heart attack signs

When a heart attack begins, a stopwatch starts. With each passing minute heart tissue is deprived of blood, causing it to deteriorate or die. In order to minimize damage to the heart, blood flow must be restored promptly, or the effects can be serious, often even fatal.

27 Apr 2011

Grant Memorial selects HMS to provide full suite of products for Petersburg hospital

Grant Memorial Hospital has selected Healthcare Management Systems Inc. to provide a full suite of integrated clinical and financial applications for the 45-bed hospital in Petersburg, W.V. Having evaluated a number of systems, Grant was impressed with HMS' ability to address its patient-care needs as a small community hospital.

27 Apr 2011

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.

27 Apr 2011

Children, adolescents with liver disease may not benefit from vitamin E or metformin

In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.

27 Apr 2011

Brain-derived protein in colorectal cancer

Tumor progression is usually ensured by more than one proliferative mechanism. When one of these is shut down by a specifically targeted drug, other mechanisms may emerge. While these events may lead to treatment failure, they may also become an opportunity for researchers to identify novel targets to be further explored.

27 Apr 2011

World could meet U.N. goal of almost ending malaria deaths by 2015, U.N. special envoy for malaria says

International efforts to fight malaria are "on track" to almost end malaria-related deaths by 2015, Ray Chambers, the U.N. secretary-general's special envoy for malaria, said on Monday, the Associated Press reports.

27 Apr 2011

Synthes, JNJ sign merger agreement for orthopaedics business

Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.

27 Apr 2011

Blueberries may help fight obesity

Recently a study out of the Texas Women's University looked at whether blueberries with their high polyphenol content could help in fighting obesity. Blueberries after all have already been cited as having positive health effects on other conditions like cardiovascular disease and metabolic syndrome. The study was conducted in Petri dishes (not live animals) using a blueberry polyphenol extract and tissue cultures from mice.

27 Apr 2011

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

ThromboGenics NV and co-development partner BioInvent International announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism after total hip surgery.

27 Apr 2011

Study finds gender difference in immune responses to PTSD

Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

27 Apr 2011

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

27 Apr 2011

Medical News

KHCC, Global Bridges to start tobacco treatment training for EMRO health care providers

LSP announces initial public offering of Life Sciences Fund on NYSE Euronext

Karo Bio reports net loss of MSEK 47.7 for January - March 2011

ISCO completes first series of hepatocytes preclinical testing

Biologists determine molecular structure of GluN2D receptor subunit

Major breakthrough in understanding of amyotrophic lateral sclerosis

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Sagent Pharma closes initial public offering of 5,750,000 shares of common stock

Dems eye Ryan Medicare plan as political opportunity

Researchers investigate new device that can recognize early heart attack signs

Grant Memorial selects HMS to provide full suite of products for Petersburg hospital

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Children, adolescents with liver disease may not benefit from vitamin E or metformin

Brain-derived protein in colorectal cancer

World could meet U.N. goal of almost ending malaria deaths by 2015, U.N. special envoy for malaria says

Synthes, JNJ sign merger agreement for orthopaedics business

Blueberries may help fight obesity

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

Study finds gender difference in immune responses to PTSD

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News